Torrent Pharmaceuticals Limited has informed the Exchange about Investor Presentation

20th May, 2025

The Dy. General Manager (Listing Dept.) BSE Limited, Corporate Relationship Dept., 1st Floor, New Trading Ring, P. J. Towers, Dalal Street, Fort, Mumbai - 400 001 (BSE Scrip Code: 500420)

The Manager – Listing Dept., National Stock Exchange of India Ltd., Exchange Plaza, 5th Floor, Plot No. C/1, G. Block, Bandra - Kurla Complex, Bandra (E), Mumbai – 400 051 (NSE Scrip Code: TORNTPHARM)

Dear Sir,

Sub.: Presentation to analysts on Audited Financial Results for the quarter and year ended

31st March, 2025

The presentation on Audited Financial Results for the quarter and year ended 31st March, 2025 to be made to analysts is enclosed for your records.

Thanking you,

Yours sincerely,

For TORRENT PHARMACEUTICALS LIMITED

CHINTAN M. TRIVEDI COMPANY SECRETARY

Encl : A/a

___________________________________________________________________________________ TORRENT PHARMACEUTICALS LIMITED CIN: L24230GJ1972PLC002126 Reg.Office : Torrent House, Off Ashram Road, Ahmedabad- 380 009, India. Phone: +91 79 26599000, Fax: +91 79 26582100, www.torrentpharma.com, Email : InvestorServices@TorrentPharma.com

Q4 FY 2024-25

Revenues: Summary

1

Revenue: Summary

Revenues (Rs cr)

Q4 FY25

Q4 FY24

Gr%

India

United States

Germany

Brazil

Others

Total

1,545

1,380

302

286

351

475

262

280

372

451

2,959

2,745

12%

15%

2%

-6%

5%

8%

2

Revenue: Summary

Revenues (Rs cr)

India

United States

Germany

Brazil

Others

Total

FY25

6,393

1,100

1,139

1,100

1,784

FY24

5,666

1,078

1,074

1,126

1,784

11,516

10,728

Gr%

13%

2%

6%

-2%

0%

7%

3